Merz Aesthetics announced today that they have received FDA approval for Xeomin® (incobotulinumtoxin) for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines or the "elevens" in adult patients. This now presents a third option in the head-to-head battle that has been taking place between Botox® (Allergan) […]